| Literature DB >> 34421555 |
Maria Jesus Herrero1, Li Wang1, David Hernandez-Pineda1, Payal Banerjee2, Heidi Y Matos1, Meredith Goodrich1, Aswini Panigrahi3, Nathan Anthony Smith1, Joshua G Corbin1.
Abstract
In humans, mutations in the transcription factor encoding gene, FOXP2, are associated with language and Autism Spectrum Disorders (ASD), the latter characterized by deficits in social interactions. However, little is known regarding the function of Foxp2 in male or female social behavior. Our previous studies in mice revealed high expression of Foxp2 within the medial subnucleus of the amygdala (MeA), a limbic brain region highly implicated in innate social behaviors such as mating, aggression, and parental care. Here, using a comprehensive panel of behavioral tests in male and female Foxp2 +/- heterozygous mice, we investigated the role Foxp2 plays in MeA-linked innate social behaviors. We reveal significant deficits in olfactory processing, social interaction, mating, aggressive, and parental behaviors. Interestingly, some of these deficits are displayed in a sex-specific manner. To examine the consequences of Foxp2 loss of function specifically in the MeA, we conducted a proteomic analysis of microdissected MeA tissue. This analyses revealed putative sex differences expression of a host of proteins implicated in neuronal communication, connectivity, and dopamine signaling. Consistent with this, we discovered that MeA Foxp2-lineage cells were responsive to dopamine with differences between males and females. Thus, our findings reveal a central and sex-specific role for Foxp2 in social behavior and MeA function.Entities:
Keywords: Foxp2; aggression; medial amygdala (MeA); proteomics; sex-specific differences; social behavior
Year: 2021 PMID: 34421555 PMCID: PMC8374433 DOI: 10.3389/fnbeh.2021.706079
Source DB: PubMed Journal: Front Behav Neurosci ISSN: 1662-5153 Impact factor: 3.558
Figure 1Decreased social interaction in female Foxp2+/– mice in the 3-chambered task. Compared to control mice, female Foxp2+/– mice show a significant decrease in time spent in the presence of a social cue (mouse; p = 0.0004, Foxp2+/– n = 13, ctr n = 12), with a correspondingly significant increase in time spent in the presence of a non-social object (wire cup; p = 0.01) (A). In contrast, male Foxp2+/– mice showed no significant changes in time spent in social or non-social interactions compared to control (p = 0.89, Foxp2+/– n = 13, ctr n = 12) (B). When directly comparing male and female Foxp2+/– mice, a significant decrease was observed in social interaction in females compared to males, with no change in non-social interaction (C; p** ≤ 0.01; p*** ≤ 0.001).
Figure 2Female and male Foxp2+/– mice display decreased time spent investigating different odors. Mice were exposed to different odors (e.g. neutral: water; non-social: peanut butter; and social: female or male urine) three times each for 2 min (with intervals of 2 min between odor exposure). Both female and male Foxp2+/– mice spent significantly less time sniffing a non-social motivating odor (peanut) than control mice (A,B). Additionally, female Foxp2+/– mice spent significantly less time sniffing both a neutral odor and a social motivating odor (male urine) (B). The experiment was repeated in two different cohorts (Foxp2+/– n = 13, ctr n = 12; p* ≤ 0.05; p** ≤ 0.01).
Figure 3Impaired mating behavior in Foxp2+/– mice. The mating repertoire of mounting, intromission, and ejaculation was recorded over a 30 min period. While the number of mounts was unchanged in female Foxp2+/– mice, male Foxp2+/– mice displayed a decreased number of mounts compared to controls (A–D). In contrast, female Foxp2+/– mice displayed a greater latency to mount than controls, a phenotype that was not observed in male Foxp2+/– mice (B,E). The duration of events was unchanged in female Foxp2+/– mice (C), with a decrease in the duration of mounts in male Foxp2+/– mice compared (F). All other parameters were unchanged (A–F). Experiment was repeated in two different cohorts (total females: Foxp2+/– n = 14, ctr n = 13; total males: Foxp2+/– n = 10, ctr n = 10). Trials were repeated three times separated by at least 1 week (total of 81 trials for females, 60 trials for males). p* ≤ 0.05; p** ≤ 0.01.
Figure 4Increased maternal aggression in Foxp2+/– mice. An intruder C57BL/6J male was introduced for 15 min to the home-cage of either a lactating Foxp2+/– or ctr female mice after removal of pups. Female Foxp2+/– mice displayed a decreased number and duration of nips (A,C), but no change in the latency of nips compared to control (B). In contrast, the number and latency of attacks was significantly increased (D,E) with no change in the duration of attacks (F). Trials were repeated two times separated by at least 1 week (Foxp2+/– n = 10, ctr n = 12). p* ≤ 0.05; p** ≤ 0.01.
Figure 5Decreased male territorial aggression in Foxp2+/– mice. An intruder C57BL/6J male was introduced into the home-cage of either a Foxp2+/– or ctr male for 10 min. Male Foxp2+/– mice displayed a significant decrease in both the number and duration of attacks compared to ctr (A,C). However, male Foxp2+/– mice did not display any differences in latency to first attack or social exploration, or difference in latency to first attack or social exploration compared to ctr (B,D,E). The total duration of social exploration was also unchanged (F) (Foxp2+/– n = 10, ctr n = 10). p** ≤ 0.01.
Figure 6Female Foxp2+/– mice display deficits in maternal behavior. To examine pup retrieval, a Foxp2+/– or ctr dam was removed from the cage and their pups were removed from the nest and placed in a far corner. When placed back into the home-cage, Foxp2+/– dams displayed a significantly greater latency to retrieve one or two pups than ctr dams (A,B). Additionally, female Foxp2+/– mice had significantly less pups per litter (C). For (A,B). Trials were repeated two times separated by at least 1 week in two different cohorts (total number of dams: Foxp2+/– n = 10, ctr n = 13; one litter per dam). p* ≤ 0.05.
Figure 7Females Foxp2+/– mice display impaired predator odor avoidance. Ctr female mice exposed to the aversive odor of rat bedding display significantly decreased number (A) and duration (B) of sniffs to the aversive odor when compared to a benign odor (unsoiled bedding). In contrast, female Foxp2+/– mice do not display a change in either number (A) or duration (B) of sniffs to rat bedding compared to a benign odor. Ctr female mice also display the stereotypical risk assessment behavior to rat bedding, as defined by an increased number (C) and duration (D) of risk assessments as compared to benign odor. In contrast, female Foxp2+/– mice do not display risk assessment behavior (C,D). Ctr female mice also display stereotypical escape behaviors to rat bedding, observed as a significant increase in the number of climbs (E) and duration of climbing (F) compared to benign odor. In contrast, this escape behavior is not observed in female Foxp2+/– mice (E,F). The experiment was repeated in four different cohorts (total: Foxp2+/– n = 10, ctr n = 10). p* ≤ 0.05; p** ≤ 0.01. NS, not significant.
Summary of behavioral changes in Foxp2+/– mice.
| Behavior | female | male |
|---|---|---|
| Social interaction | ↓ | NC |
| Olfactory Habituation/Dishabituation | ⇊ | ↓ |
| Mating | ↓ | ⇊ |
| Aggression | ↑ | ↓ |
| Parenting | ↓ | ND |
| Predator Odor Avoidance | ↓ | ND |
NC, no change; ND, not determined; Downward arrows reflect a significant decrease in the presentation of a given behavior, while upward arrows indicate an significant increase in the presentation of behavior. Double arrows indicate a stronger phenotype. A subset of behavioral changes differed in either the magnitude (olfactory habituation/dishabituation, mating) or presentation (aggression) between Foxp2.
Figure 8Overlapping and non-overlapping changes in protein expression in the MeA of female and male Foxp2+/– mice. Venn Diagram of the differentially expressed proteins in the three comparisons from Figure 8: Foxp2+/– female vs. ctr female (mtF/ctrF), Foxp2+/– male vs. ctr male (mtM/ctrM), and Foxp2+/– female vs. Foxp2+/– male (mtF/mtM; Log2F C≥ |1.11|). The signature of proteins and neuromodulators in the amygdala of Foxp2+/– mice was sex-specific.
Figure 9Heatmaps of differentially expressed proteins in the MeA of female and male Foxp2+/– mice. Pooled microdissected MeA tissue from thee brains was run in duplicate. Ratios for each duplicate are shown in the x-axis and protein names (symbols) of differentially expressed proteins are displayed on the y-axis on the right. Panels (A–C) show proteins significantly upregulated (red) or downregulated (green) in three comparisons: Foxp2+/– female vs. ctr female (mtF/ctrF) (A), Foxp2+/– male vs. ctr male (mtM/ctrM) (B), Foxp2+/– female vs. Foxp2+/– male (mtF/mtM) (C) (Log2 fold change ≥ |1.11|). Proteins were clustered based on similarity of expression between the experimental and control groups, which is indicated by the dendrogram. The color key and histogram panel indicates the Z-scores of expression and the expression counts. See Supplementary Table 1 for a full list of altered proteins in each comparison.
Figure 10Pie charts of enriched Ontology (GO) terms for the proteins differentially expressed in the MeA of female and male Foxp2+/– mice. Ontology analysis in the three comparisons: Foxp2+/– female vs. ctr female (mtF/ctrF), Foxp2+/– male vs. ctr male (mtM/ctrM), Foxp2+/– female vs. Foxp2+/– male (mtF/mtM). Myelin sheath was a common term for the three comparisons (colored in white). Common terms across (A,B; i.e., Ensheathment of neurons, NAD binding, Cellular aldehyde metabolic process) and (A,C; Association of DFF40 with chromatin, Cytosolic large ribosomal subunit, Extracellular exosome) are colored in scales of gray. Selected terms and related metrics were determined using ClueGO, based on the terms per group with the highest percentages.
Enriched ontology GO terms and associated proteins.
| GO Term | List of associated proteins | |
|---|---|---|
| mtF/CtrF | Regulation of coagulation | [ANXA2, ANXA5, CAV1, CD9, FGA, FGG] |
| Association of DFF40 with chromatin | [H1F0, HIST1H1A, HIST1H1B, HIST1H1C, HIST1H1E] | |
| Ensheathment of neurons | [BCAS1, CD9, CLDN11, MAG, NTRK3, PLP1, S100B, SIRT2] | |
| Receptor internalization | [CAV1, CD81, CD9, HPCA, LRRTM1, SIRT2] | |
| Cytosolic large ribosomal subunit | [RPL13, RPL14, RPL18, RPL19, RPL24, RPL34, RPL35, RPL4, RPL6, RPL7A, RPL8] | |
| Regulation of hemostasis | [ANXA2, ANXA5, CAV1, CD9, FGA, FGG] | |
| Positive regulation of cytoskeleton organization | [APOA1, BRK1, CAV1, FLNA, IQGAP2, NCK2, NTRK3, PLP1] | |
| Regeneration | [APOA1, CCN3, CD81, CD9, GFAP, MAG, MTPN, NEFL, NTRK3, TNC] | |
| Receptor metabolic process | [ANXA2, CAV1, CD81, CD9, HPCA, LRRTM1, SIRT2] | |
| Long-term synaptic potentiation | [CALB1, CALB2, GFAP, LRRTM1, S100B] | |
| Extracellular exosome | [AHNAK, ANPEP, ANXA2, CD81, CD9] | |
| Regulation of cell adhesion molecule production | [APOA1, AQP4, CAV1] | |
| Calcium-dependent protein binding | [ANXA2, MYO1D, NSMF, S100B, WFS1] | |
| Regulation of protein depolymerization | [MTPN, PLP1, SH3BP1] | |
| Response to zinc ion | [ALAD, CRIP1, MT1] | |
| Myelin sheath | [ANXA2, CLDN11, CNP, CRYAB, GFAP, INA, MAG, MOBP, MOG, MYO1D, NEFL, PLP1, SIRT2] | |
| NAD binding | [ALDH1A1, NNT, SIRT2] | |
| Cellular aldehyde metabolic process | [ALDH1A1, GLO1, PLP1] | |
| Perikaryon | [ANXA5, CRYAB, HPCA, MYO1D, NSMF, PDE11A, SIRT2] | |
| Actin filament bundle | [CRYAB, FLNA, SIPA1L3] | |
| mtM/CtrM | Localization within membrane | [AKAP5, CD81, HAP1, LRRC7, RILPL1, SHISA6, SIRT2] |
| Postsynapse organization | [CDKL5, IGF1R, INA, ITPKA, NEFH, NEFL, SHISA6, WASF2] | |
| Ensheathment of neurons | [BCAS1, CD9, CLDN11, MAG, MBP, PLLP, PLP1, SIRT2, TSPAN2] | |
| Cellular protein complex disassembly | [AKAP5, CCSAP, PLP1, SH3BP1, TMOD1] | |
| Leading edge membrane | [AKAP5, CDKL5, LAMP5, MYO1D, PLP1, PSD3, SHISA6] | |
| Regulation of dendrite morphogenesis | [AKAP5, CDKL5, ITPKA, SDC2] | |
| Myelin sheath | [CLDN11, CNP, CRYAB, EHD2, ERMN, INA, MAG, MBP, MOBP, MOG, MYO1D, NEFH, NEFL, PLLP, PLP1, SIRT2, TSPAN2] | |
| Myosin binding | [HAP1, MOBP, MYL9, RAB3B] | |
| Longevity regulating pathway | [ADCY8, CRYAB, IGF1R] | |
| Regulation of meiotic cell cycle | [CNP, IGF1R, SIRT2] | |
| NAD binding | [ALDH1A1, ME3, SIRT2] | |
| Cellular aldehyde metabolic process | [ALDH1A1, ALDH3B1, PLP1] | |
| Exocytosis of secretory granule membrane proteins | [ALDH3B1, AP2A2, RHOG] | |
| mtF/mtM | Association of DFF40 with chromatin | [H1F0, HIST1H1A, HIST1H1B, HIST1H1C, HIST1H1E] |
| Cytosolic large ribosomal subunit | [RPL13, RPL14, RPL18, RPL19, RPL24, RPL34, RPL35, RPL4, RPL6, RPL7, RPL7A, RPL8] | |
| Protein transport within lipid bilayer | [DNM1, HPCA, PPP3R1, RFTN1, SCRIB] | |
| MHC class II antigen presentation | [CLTA, DCTN5, DNM1, SEC24A, TUBAL3] | |
| Myelin sheath | [AKR1B3, ALB, ANXA2, DNM1, GSTM1, LDHB, MBP, MDH1, SCRIB, UCHL1] | |
| Diterpenoid metabolic process | [AKR1B3, ALDH1A1, RBP1] | |
| Pyruvate metabolism | [GLO1, LDHB, MDH1, ME3] | |
| Cysteine-type endopeptidase inhibitor activity | [CSTB, MT3, NOL3, PRDX6] | |
| Catecholamine metabolic process | [AKR1B3, MTPN, SNCB] | |
| Extracellular exosome | [ALB, ANPEP, ANXA2, IDE] | |
| Regulation of protein targeting | [HPCA, NOL3, TOMM7] |
Listed proteins differentially expressed in the MeA of Foxp2+/− mice associated to the enriched ontology terms (in .
Detailed information on the biological function of the 15 ASD and three dopamine related proteins differentially expressed in the MeA.
| Symbol | Comp. | Related | Cat. | Description | References |
|---|---|---|---|---|---|
| BCAS1 | 1,2 | ASD | 3 | Ishimoto et al. ( | |
| CD38 | 1 | ASD | 3 | Martucci et al. ( | |
| CD99L2 | 3 | ASD | 3 | Ramos et al. ( | |
| CDKL5 | 2 | ASD | 1 | Tang et al. ( | |
| ERMN | 2 | ASD | 3 | Galvez-Contreras et al. ( | |
| FGA | 1 | ASD | 3 | Yang et al. ( | |
| GLO1 | 1,3 | ASD | 3 | Kovač et al. ( | |
| GSTM1 | 3 | ASD | 3 | Yochum et al. ( | |
| LRRC4C | 2 | ASD | 1-Satt. | Um et al. ( | |
| NFIB | 2 | ASD | Synd. | Hickey et al. ( | |
| NTRK3 | 1,3 | ASD | 3 | Chakrabarti et al. ( | |
| PSD3 | 1,2 | ASD | 3 | Pinto et al. ( | |
| SDC2 | 1,2 | ASD | 3 | Hu et al. ( | |
| SRPR | 1 | ASD | Satt. | Sun et al. ( | |
| GFAP | 1 | ASD /DOPA | 1-Satt. | Edmonson et al. ( | |
| DNM1 | 3 | DOPA | Bonnycastle ( | ||
| FLNA | 1 | DOPA | Coelho et al. ( |
Column “Comp.” states in which comparison(s) each of these proteins were differentially expressed (i.e., 1: .
Figure 11Foxp2-lineage cells in MeA are more responsive to dopamine in females. Dopamine evoked Ca2+ transients were assessed in 300 μm MeA slices from Foxp2;GCaMP5G-tdTM mice. Time series of Ca2+ increases in Foxp2-lineage cells by focal application of dopamine (100 mM) from a glass pipette (white dotted line) is shown: in red the recombined Foxp2-lineage cells, in green the Ca++ transient (A). The pseudocolor scale displays changes in GCaMP5G △F/F. Representative individual traces of GCaMP5G fluorescence changes (△F/F) in response to dopamine (B). The color-coding of the traces matches the ROI of the colored circles in (A). Dopamine evoked significantly more activation in Foxp2-lineage cells in females than in males (C). Analysis was carried out in n = 5 females, n = 4 males in at least two slices per animal containing the MeA. *p ≤ 0.05 (p = 0.0294).